Hysteroscopic Endometrial Ablation: From Indications to Instrumentation and Techniques-A Call to Action.
ablation
abnormal uterine bleeding
endometrial ablation
endometrium
heavy menstrual bleeding
hysterectomy
hysteroscopy
myoma
polyp
resectoscope
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
17 Jan 2023
17 Jan 2023
Historique:
received:
11
10
2022
revised:
15
01
2023
accepted:
16
01
2023
entrez:
11
2
2023
pubmed:
12
2
2023
medline:
12
2
2023
Statut:
epublish
Résumé
The development of minimally invasive techniques has led to the creation of innovative alternatives in cases where traditional methods are not applicable. In modern gynecology, hysteroscopy has become the gold standard for the evaluation and treatment of intrauterine pathology. Endometrial ablation (EA) is a procedure that uses different types of energy to destroy the endometrium and is currently used as an alternative technique in cases of heavy menstrual bleeding when medical treatment has failed and uterine preservation is desired. The aim of this review was to evaluate the feasibility, safety, and clinical outcomes of hysteroscopic EA as an alternative in patients with abnormal uterine bleeding. A detailed computerized search of the literature was performed in the main electronic databases (MEDLINE, EMBASE, Web of Science, PubMed, and Cochrane Library), from 1994 to June 2022, to evaluate the outcomes in patients with abnormal uterine bleeding (AUB) undergoing EA using hysteroscopic and non-hysteroscopic techniques. Only scientific publications in English were included. Twelve articles on the current use of endometrial ablation were included. Data on patient symptoms, tools used for EA, primary outcomes, and adverse events were recorded. EA should be considered an effective and safe approach in the management of patients with abnormal uterine bleeding caused by benign pathology, in whom medical treatment has failed or is contraindicated. Due to the lack of evidence, it would be interesting to determine whether EA would also have a role in the treatment of women with premalignant lesions, avoiding invasive surgical procedures or medical treatment in those patients for whom hysterectomy or the use of hormonal treatment is contraindicated.
Identifiants
pubmed: 36766443
pii: diagnostics13030339
doi: 10.3390/diagnostics13030339
pmc: PMC9914843
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Best Pract Res Clin Obstet Gynaecol. 2005 Aug;19(5):713-26
pubmed: 16023413
Obstet Gynecol. 2000 Aug;96(2):266-70
pubmed: 10908775
Biomed Res Int. 2017;2017:6848250
pubmed: 28948169
Obstet Gynecol. 2014 Nov;124(5):904-910
pubmed: 25437717
Climacteric. 2020 Aug;23(4):369-375
pubmed: 32368939
J Minim Invasive Gynecol. 2013 Jul-Aug;20(4):487-91
pubmed: 23870238
Int J Gynaecol Obstet. 2000 Dec;71(3):283-4
pubmed: 11102628
J Am Assoc Gynecol Laparosc. 2004 Feb;11(1):59-61
pubmed: 15104833
J Obstet Gynaecol Res. 2015 Dec;41(12):1935-41
pubmed: 26534903
Curr Opin Obstet Gynecol. 2003 Aug;15(4):303-8
pubmed: 12858102
Obstet Gynecol. 2017 Sep;130(3):554-560
pubmed: 28796675
Diagnostics (Basel). 2022 May 09;12(5):
pubmed: 35626331
Hum Reprod. 2001 Jan;16(1):168-171
pubmed: 11139557
J Minim Invasive Gynecol. 2017 Nov - Dec;24(7):1104-1110
pubmed: 28843536
Acta Obstet Gynecol Scand. 2009;88(2):227-30
pubmed: 19023681
Obstet Gynecol Clin North Am. 2000 Jun;27(2):347-66
pubmed: 10857125
J Minim Invasive Gynecol. 2013 Sep-Oct;20(5):642-7
pubmed: 23791400
Minerva Ginecol. 2016 Dec;68(6):722-6
pubmed: 26954490
BMJ Clin Evid. 2015 Sep 18;2015:
pubmed: 26382038
J Am Assoc Gynecol Laparosc. 2003 Nov;10(4):491-5; discussion 495
pubmed: 14738636
Clin Exp Obstet Gynecol. 2014;41(3):335-8
pubmed: 24992788
Fam Pract. 2017 Nov 16;34(6):673-678
pubmed: 28586411
Gynecol Surg. 2011 May;8(2):193-196
pubmed: 21654903
Am J Obstet Gynecol. 2019 Dec;221(6):629.e1-629.e18
pubmed: 31310749
Int J Gynecol Cancer. 2022 Jul 26;:
pubmed: 35882425
J Minim Invasive Gynecol. 2010 May-Jun;17(3):344-50
pubmed: 20417426
Minim Invasive Ther Allied Technol. 2021 Oct;30(5):288-295
pubmed: 34218728
Eur J Gynaecol Oncol. 2002;23(2):151-3
pubmed: 12013114
Acta Oncol. 2016;55(2):188-92
pubmed: 26243443
Diagnostics (Basel). 2021 Mar 04;11(3):
pubmed: 33806571
J Minim Invasive Gynecol. 2008 Jul-Aug;15(4):466-71
pubmed: 18588849
Am J Obstet Gynecol. 2014 Nov;211(5):556.e1-6
pubmed: 25019488
J Clin Med. 2020 Jul 03;9(7):
pubmed: 32635369
Oman Med J. 2017 Nov;32(6):492-498
pubmed: 29218126
Acta Obstet Gynecol Scand. 2007;86(4):480-3
pubmed: 17486472
Circulation. 2019 Sep 10;140(11):e563-e595
pubmed: 30879339
Hum Reprod. 2002 Nov;17(11):2795-806
pubmed: 12407030
Minim Invasive Ther Allied Technol. 2021 Jun;30(3):147-153
pubmed: 31855088
Fertil Steril. 2003 Jul;80(1):199-202
pubmed: 12849824
J Minim Invasive Gynecol. 2010 Jul-Aug;17(4):436-48
pubmed: 20621007
Eur J Obstet Gynecol Reprod Biol. 2016 Nov;206:32-35
pubmed: 27632410
Fertil Steril. 2008 Feb;89(2):438-43
pubmed: 17482613
Int J Gynaecol Obstet. 2011 Apr;113(1):3-13
pubmed: 21345435
Updates Surg. 2020 Mar;72(1):213-218
pubmed: 31993995
Int J Gynaecol Obstet. 2008 Apr;101(1):39-42
pubmed: 18078939
Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):210-4
pubmed: 18248873
Int J Gynaecol Obstet. 2022 Jan;156(1):112-118
pubmed: 33615469
Fertil Steril. 2004 Nov;82(5):1395-401
pubmed: 15533366
Gynecol Endocrinol. 2014 Feb;30(2):149-52
pubmed: 24303914
J Minim Invasive Gynecol. 2020 Sep - Oct;27(6):1414-1416
pubmed: 31884079
Fertil Steril. 2003 Feb;79(2):418-21
pubmed: 12568856
Res Integr Peer Rev. 2019 Mar 26;4:5
pubmed: 30962953
Womens Health (Lond). 2016 Jan;12(1):45-52
pubmed: 26756668
Obstet Gynecol. 2003 Dec;102(6):1278-82
pubmed: 14662215
J Minim Invasive Gynecol. 2015 Jul-Aug;22(5):792-8
pubmed: 25796220
BJOG. 2011 Sep;118(10):1171-9
pubmed: 21624035
Cochrane Database Syst Rev. 2002;(3):CD001124
pubmed: 12137619
J Minim Invasive Gynecol. 2019 Sep - Oct;26(6):1169-1176
pubmed: 30528831
Int J Gynaecol Obstet. 2021 Dec;155(3):425-432
pubmed: 33686708
J Minim Invasive Gynecol. 2015 Nov-Dec;22(7):1225-30
pubmed: 26149205
Hum Reprod. 2003 Nov;18(11):2441-5
pubmed: 14585898
J Obstet Gynaecol Can. 2015 Apr;37(4):362-79
pubmed: 26001691
Arch Gynecol Obstet. 2017 Jan;295(1):3-7
pubmed: 27834002
Minerva Ginecol. 2016 Apr;68(2):143-53
pubmed: 26928420
Ginekol Pol. 2018;89(7):398-404
pubmed: 30091451
J Minim Invasive Gynecol. 2005 Jan-Feb;12(1):62-6
pubmed: 15904601
Reprod Biomed Online. 2020 Jul;41(1):55-61
pubmed: 32444259
Cochrane Database Syst Rev. 2003;(2):CD003855
pubmed: 12804492
BJOG. 2013 Jul;120(8):966-70
pubmed: 23759085
Am J Obstet Gynecol. 2022 Apr;226(4):487-498.e8
pubmed: 34555319
BMJ. 1994 Oct 15;309(6960):979-83
pubmed: 7772106
PLoS One. 2019 Jul 10;14(7):e0219294
pubmed: 31291298
Rev Bras Ginecol Obstet. 2017 Jul;39(7):358-368
pubmed: 28605821
Am J Obstet Gynecol. 2023 Jan;228(1):22-35.e2
pubmed: 35932873
Expert Opin Drug Saf. 2022 Apr;21(4):477-486
pubmed: 34612122
Gynecol Oncol. 2020 Aug;158(2):347-353
pubmed: 32467056
J Minim Invasive Gynecol. 2021 Aug;28(8):1536-1543
pubmed: 33444791